Literature DB >> 11545686

Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy.

H Takashima1, C F Boerkoel, J R Lupski.   

Abstract

PURPOSE: To determine the efficacy of denaturing high-performance liquid chromatography (DHPLC) for mutation detection in genetically heterogeneous diseases using Charcot-Marie-Tooth neuropathy as a model.
METHODS: (1) Identification of the optimal conditions for mutation scanning by DHPLC using 50 known variants of PMP22, MPZ, GJB1 and EGR2. (2) Comparison of DHPLC with DNA sequencing for mutation detection in 168 patient DNA samples.
RESULTS: We established the optimal conditions for screening PMP22, MPZ, GJB1, and EGR2 for mutations. Under optimized conditions, DHPLC was as sensitive as DNA sequencing and detected two mutations that were not identified by automated DNA sequence.
CONCLUSIONS: DHPLC increases the efficiency and sensitivity of mutation screening in genetically heterogeneous diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545686     DOI: 10.1097/00125817-200109000-00002

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  7 in total

Review 1.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Use of GC clamps in DHPLC mutation scanning.

Authors:  Robert J Wurzburger; Rajarsi Gupta; Andrew P Parnassa; Sargam Jain; Jason A Wexler; Jia Li Chu; Keith B Elkon; Robert D Blank
Journal:  Clin Med Res       Date:  2003-04

3.  Compound Charcot-Marie-Tooth disease may determine unusual and milder phenotypes.

Authors:  Silmara P Gouvea; Vinícius H S Borghetti; Keity C Bueno; Adriana B Genari; Charles M Lourenço; Claudia Sobreira; Amilton A Barreira; Wilson Marques
Journal:  Neurogenetics       Date:  2009-08-25       Impact factor: 2.660

4.  Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation.

Authors:  Katharine M Brauch; Lin Y Chen; Timothy M Olson
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

5.  Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.

Authors:  G Piluso; L Politano; S Aurino; M Fanin; E Ricci; V M Ventriglia; A Belsito; A Totaro; V Saccone; H Topaloglu; A C Nascimbeni; L Fulizio; A Broccolini; N Canki-Klain; L I Comi; G Nigro; C Angelini; V Nigro
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

6.  Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients.

Authors:  Na Young Jung; Hye Mi Kwon; Da Eun Nam; Nasrin Tamanna; Ah Jin Lee; Sang Beom Kim; Byung-Ok Choi; Ki Wha Chung
Journal:  Genes (Basel)       Date:  2022-07-08       Impact factor: 4.141

7.  Efficient IDUA Gene Mutation Detection with Combined Use of dHPLC and Dried Blood Samples.

Authors:  Diogo Ribeiro; Ana Cardoso; Ana Joana Duarte; Luis Vieira; Olga Amaral
Journal:  ISRN Mol Biol       Date:  2013-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.